Kunihiro Matsushita

Kunihiro Matsushita

Johns Hopkins University

H-index: 89

North America-United States

About Kunihiro Matsushita

Kunihiro Matsushita, With an exceptional h-index of 89 and a recent h-index of 72 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Cardiovascular Disease, Chronic Kidney Disease, Risk Prediction.

His recent articles reflect a diverse array of research interests and contributions to the field:

Metabolomic Association and Risk Prediction With Heart Failure in Older Adults

Discrepancies between cystatin C–based and creatinine-based eGFR

Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study

Racial differences in trends and prognosis of guideline-directed medical therapy for heart failure with reduced ejection fraction: the Atherosclerosis Risk in Communities (ARIC …

Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis

Incidence of dementia following hospitalization with infection among adults in the atherosclerosis risk in communities (ARIC) study cohort

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Effects of cuff size on the accuracy of blood pressure readings: the Cuff (SZ) randomized crossover trial

Kunihiro Matsushita Information

University

Johns Hopkins University

Position

Associate Professor of Epidemiology and Medicine

Citations(all)

93725

Citations(since 2020)

57656

Cited By

45242

hIndex(all)

89

hIndex(since 2020)

72

i10Index(all)

304

i10Index(since 2020)

281

Email

University Profile Page

Johns Hopkins University

Kunihiro Matsushita Skills & Research Interests

Cardiovascular Disease

Chronic Kidney Disease

Risk Prediction

Top articles of Kunihiro Matsushita

Metabolomic Association and Risk Prediction With Heart Failure in Older Adults

Authors

Guning Liu,Ngoc Quynh H Nguyen,Kari E Wong,Sunil K Agarwal,Eric Boerwinkle,Patricia P Chang,Brian L Claggett,Laura R Loehr,Jianzhong Ma,Kunihiro Matsushita,Carlos J Rodriguez,Joseph S Rossi,Stuart D Russell,R Brandon Stacey,Amil M Shah,Bing Yu

Journal

Circulation: Heart Failure

Published Date

2024/3/1

BACKGROUND Older adults have markedly increased risks of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). Identifying novel biomarkers can help in understanding HF pathogenesis and improve at-risk population identification. This study aimed to identify metabolites associated with incident HF, HFpEF, and HF with reduced ejection fraction and examine risk prediction in older adults. METHODS Untargeted metabolomic profiling was performed in Black and White adults from the ARIC study (Atherosclerosis Risk in Communities) visit 5 (n=3719; mean age, 75 years). We applied Cox regressions to identify metabolites associated with incident HF and its subtypes. The metabolite risk score (MRS) was constructed and examined for associations with HF, echocardiographic measures, and HF risk prediction. Independent samples from visit 3 (n=1929; mean age, 58 years) were used for …

Discrepancies between cystatin C–based and creatinine-based eGFR

Authors

Danielle K Farrington,Aditya Surapaneni,Kunihiro Matsushita,Jesse C Seegmiller,Josef Coresh,Morgan E Grams

Journal

Clinical Journal of the American Society of Nephrology

Published Date

2023/9/1

BackgroundRecent guidance suggests clinicians increase use of cystatin C for the estimation of GFR. Discrepant levels of creatinine-versus cystatin C–based eGFR (eGFRcr versus eGFRcys) can occur and might signify inaccurate estimation of GFR using creatinine alone. This study sought to enhance the knowledge of the risk factors and clinical implications of having a large eGFR discrepancy.MethodsParticipants in the Atherosclerosis Risk in Communities Study, a prospective cohort study of US adults, were followed over 25 years. eGFR discrepancy was measured at five clinical visits and defined as eGFRcys either 30% lower or higher than eGFRcr, the current clinical standard of care. The associations between eGFR discrepancies and kidney-related laboratory parameters were assessed using linear and logistic regression and long-term adverse outcomes, including kidney failure, AKI, heart failure, and death …

Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study

Authors

Xiaoming Jia,Leo Buckley,Caroline Sun,Mahmoud Al Rifai,Bing Yu,Vijay Nambi,Salim S Virani,Elizabeth Selvin,Kunihiro Matsushita,Ron C Hoogeveen,Josef Coresh,Amil M Shah,Christie M Ballantyne

Journal

European Journal of Preventive Cardiology

Published Date

2023/11

Aims Interleukin-6 (IL-6) and interleukin-18 (IL-18), important cytokines implicated in atherosclerosis and inflammaging, were assessed for associations with global cardiovascular disease (CVD), atrial fibrillation (AF), and death in older adults. Methods and results Participants from Atherosclerosis Risk in Communities study Visit 5 (mean age 75.4 ± 5.1 years) with IL-6 and IL-18 measurements were included (n = 5672). Cox regression models were used to assess associations of IL-6 and IL-18 with coronary heart disease (CHD), ischaemic stroke, heart failure (HF) hospitalization, global CVD (composite of CHD, stroke, and HF), AF, and all-cause death. Over a median follow-up of 7.2 years, there were 1235 global CVD events, 530 AF events, and 1173 deaths. Higher IL-6 [hazard ratio (HR) 1.57, 95% confidence interval (CI) 1.44–1.72 per log unit increase] and IL-18 (HR 1.13 …

Racial differences in trends and prognosis of guideline-directed medical therapy for heart failure with reduced ejection fraction: the Atherosclerosis Risk in Communities (ARIC …

Authors

Lena Mathews,Ning Ding,Yingying Sang,Laura R Loehr,Jung-Im Shin,Naresh M Punjabi,Alain G Bertoni,Deidra C Crews,Wayne D Rosamond,Josef Coresh,Chiadi E Ndumele,Kunihiro Matsushita,Patricia P Chang

Journal

Journal of racial and ethnic health disparities

Published Date

2023/2/1

Background Racial disparities in guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) have not been fully documented in a community setting. Methods In the ARIC Surveillance Study (2005–2014), we examined racial differences in GDMT at discharge, its temporal trends, and the prognostic impact among individuals with hospitalized HFrEF, using weighted regression models to account for sampling design. Optimal GDMT was defined as beta blockers (BB), mineralocorticoid receptor antagonist (MRA) and ACE inhibitors (ACEI) or angiotensin II receptor blockers (ARB). Acceptable GDMT included either one of BB, MRA, ACEI/ARB or hydralazine plus nitrates (H-N). Results Of 16,455 (unweighted n = 3,669) HFrEF cases, 47% were Black. Only ~ 10% were discharged with optimal …

Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis

Authors

Lawrence J Appel,Morgan Grams,Mark Woodward,Katie Harris,Hisatomi Arima,John Chalmers,Hiroshi Yatsuya,Koji Tamakoshi,Yuanying Li,Josef Coresh,Yingying Sang,Kunihiro Matsushita,Kevan Polkinghorne,Steve Chadban,Adeera Levin,Ognjenka Djurdjev,Mila Tang,Luxia Zhang,Fang Wang,Jinwei Wang,Ming-Hui Zhao,Elke Schaeffner,Natalie Ebert,Nina Mielke,Marcello Tonelli,Anita Lloyd,Frank Sacks,Michael G Shlipak,Nisha Bansal,Mark Sarnak,Kazumasa Yamagishi,Isao Muraki,Yuji Shimizu,Hiroyasu Iso,Masafumi Fukagawa,Shoichi Maruyama,Takayuki Hamano,Naohiko Fujii,Takahiro Imaizumi,Natalia Alencar De Pinho,Marie Metzger,Bénédicte Stengel,Aghilès Hamroun,Ziad Massy,Tazeen H Jafar,Imtiaz Jehan,Juanita Hatcher,Nish Chaturvedi,Neil Poulter,David C Wheeler,Martin Landray,Amanda Anderson,Jing Chen,James Lash,Jon Taliercio,Peter Wei Yang,Katherine Tuttle,Radica Alicic,Susanne Nicholas,Jenny Shen,Ben Schöttker,Hannah Stocker,Dietrich Rothenbacher,Hermann Brenner,Daniel Levy,Shih-Jen Hwang,Markus P Schneider,Anna Köttgen,Heike Meiselbach,Kai-Uwe Eckardt,Alexander R Chang,Jamie A Green,H Lester Kirchner,Gurmukteshwar Singh,Simon Sawhney,Corri Black,Katie Wilde,Angharad Marks,Samira Bell,Moneeza Siddiqui,Colin Palmer,Ewan Pearson,Mariko Miyazaki,Masaaki Nakayama,Tae Yamamoto,Gen Yamada,Sadayoshi Ito,Massimo Cirillo,Angela Yee-Moon Wang,Henry Hon-Lin Wu,Hoi Ching Cheung,Victoria Ngai,Tang Ka Tak,Amit X Garg,Eric McArthur,Ann Young,Vivekanand Jha,Ashok Kumar Yadav,Vivek Kumar,April P Carson,Bessie A Young,Clarissa Diamantidis,Yuan-I Min,Tanjala S Purnell,Shizukiyo Ishikawa,Makiko Mieno,Kunihiro Yamagata,Kunitoshi Iseki,Koichi Asahi,Tsuneo Konta,Brian J Lee,Nigel J Brunskill,Laura Gray,Rupert Major,James Medcalf,Gabriel Chodick,Cheli Melzer Cohen,Jack FM Wetzels,Peter J Blankestijn,Arjan D van Zuilen,Lesley A Inker,Andrew S Levey,Joachim Ix,Ian de Boer,Ronit Katz,Florian Kronenberg,Barbara Kollerits,Eberhard Ritz,Dorothea Nitsch,Girish N Nadkarni,Lili Chan,Erwin P Bottinger,Wonsuk Oh,Zhihong Liu,Haitao Zhang,Lihua Zhang,Jose M Valdivielso,Marcelino Bermudez-Lopez,Milica Bozic,Maite Caus,Juan Miguel Diaz-Tocados,Benedicte Stengel,Katsuyuki Miura,Hirotsugu Ueshima,Akira Okayama,Aya Kadota,Tomonori Okamura,Laura Sola,Alejandro Ferreiro,Jose Santiago

Journal

Jama

Published Date

2023/10/3

ImportanceChronic kidney disease (low estimated glomerular filtration rate [eGFR] or albuminuria) affects approximately 14% of adults in the US.ObjectiveTo evaluate associations of lower eGFR based on creatinine alone, lower eGFR based on creatinine combined with cystatin C, and more severe albuminuria with adverse kidney outcomes, cardiovascular outcomes, and other health outcomes.Design, Setting, and ParticipantsIndividual-participant data meta-analysis of 27 503 140 individuals from 114 global cohorts (eGFR based on creatinine alone) and 720 736 individuals from 20 cohorts (eGFR based on creatinine and cystatin C) and 9 067 753 individuals from 114 cohorts (albuminuria) from 1980 to 2021.ExposuresThe Chronic Kidney Disease Epidemiology Collaboration 2021 equations for eGFR based on creatinine alone and eGFR based on creatinine and cystatin C; and albuminuria estimated as …

Incidence of dementia following hospitalization with infection among adults in the atherosclerosis risk in communities (ARIC) study cohort

Authors

Bruno Bohn,Pamela L Lutsey,Jeffrey R Misialek,Keenan A Walker,Charles H Brown,Timothy M Hughes,Junichi Ishigami,Kunihiro Matsushita,Ryan T Demmer

Journal

JAMA Network Open

Published Date

2023/1/3

ImportanceFactors associated with the risk of dementia remain to be fully understood. Systemic infections are hypothesized to be such factors and may be targets for prevention and screening.ObjectiveTo investigate the association between hospitalization with infection and incident dementia.Design, Setting, and ParticipantsData from the community-based Atherosclerosis Risk in Communities (ARIC) study, a prospective cohort study, were used. Enrollment occurred at 4 research centers in the US, initiated in 1987 to 1989. The present study includes data up to 2019, for 32 years of follow-up. Data analysis was performed from April 2021 to June 2022.ExposuresHospitalizations with infections were identified via medical record review for selectedInternational Classification of Diseases, Ninth Revision(ICD-9) andInternational Statistical Classification of Diseases and Related Health Problems, Tenth Revision(ICD-10 …

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Authors

Kunihiro Matsushita,Stephen Kaptoge,Steven HJ Hageman,Yingying Sang,Shoshana H Ballew,Morgan E Grams,Aditya Surapaneni,Luanluan Sun,Johan Arnlov,Milica Bozic,Hermann Brenner,Nigel J Brunskill,Alex R Chang,Rajkumar Chinnadurai,Massimo Cirillo,Adolfo Correa,Natalie Ebert,Kai-Uwe Eckardt,Ron T Gansevoort,Orlando Gutierrez,Farzad Hadaegh,Jiang He,Shih-Jen Hwang,Tazeen H Jafar,Simerjot K Jassal,Takamasa Kayama,Csaba P Kovesdy,Gijs W Landman,Andrew S Levey,Donald M Lloyd-Jones,Rupert W Major,Katsuyuki Miura,Paul Muntner,Girish N Nadkarni,Christoph Nowak,Takayoshi Ohkubo,Michelle J Pena,Kevan R Polkinghorne,Toshimi Sairenchi,Elke Schaeffner,Markus P Schneider,Varda Shalev,Michael G Shlipak,Marit D Solbu,Nikita Stempniewicz,James Tollitt,José M Valdivielso,Joep Van Der Leeuw,Angela Yee-Moon Wang,Chi-Pang Wen,Mark Woodward,Kazumasa Yamagishi,Hiroshi Yatsuya,Luxia Zhang,Jannick AN Dorresteijn,Emanuele Di Angelantonio,Frank LJ Visseren,Lisa Pennells,Josef Coresh

Journal

European journal of preventive cardiology

Published Date

2023/1/1

Aims The 2021 European Society of Cardiology (ESC) guideline on cardiovascular disease (CVD) prevention categorizes moderate and severe chronic kidney disease (CKD) as high and very-high CVD risk status regardless of other factors like age and does not include estimated glomerular filtration rate (eGFR) and albuminuria in its algorithms, systemic coronary risk estimation 2 (SCORE2) and systemic coronary risk estimation 2 in older persons (SCORE2-OP), to predict CVD risk. We developed and validated an ‘Add-on’ to incorporate CKD measures into these algorithms, using a validated approach. Methods In 3,054 840 participants from 34 datasets, we developed three Add-ons [eGFR only, eGFR + urinary albumin-to-creatinine ratio (ACR) (the primary Add-on), and eGFR + dipstick proteinuria] for SCORE2 and SCORE2-OP. We validated C-statistics and net …

Effects of cuff size on the accuracy of blood pressure readings: the Cuff (SZ) randomized crossover trial

Authors

Junichi Ishigami,Jeanne Charleston,Edgar R Miller,Kunihiro Matsushita,Lawrence J Appel,Tammy M Brady

Journal

JAMA internal medicine

Published Date

2023/10/1

ImportanceClinical practice guidelines recommend selecting an appropriately sized cuff based on mid-arm circumference prior to measuring blood pressure (BP). To our knowledge, the effect of miscuffing on BP measurement when using an automated BP device has not been quantified.ObjectiveTo determine the effect of using a regular BP cuff vs an appropriately sized BP cuff on automated BP readings.Design, Setting, and ParticipantsThis randomized crossover trial of community-dwelling adults with a wide range of mid-arm circumferences took place between March 16 and October 25, 2021, in Baltimore, Maryland. Participants were recruited via BP screening events at a public food market and a senior housing facility, targeted mailings to prior research participants, placement of study brochures in hypertension clinics at Johns Hopkins University, and referrals from physicians providing hypertension care to …

Prevalence of chronic kidney disease in Asia: a systematic review and analysis

Authors

Yusra Habib Khan,Tauqeer Hussain Mallhi,Azmi Sarriff,Amer Hayat Khan,Nida Tanveer

Published Date

2018/12/1

Chronic kidney disease (CKD) is an asymptomatic disease associated with high morbidity and life-threatening complications that lead to decreased life expectancy. Worldwide prevalence of CKD is escalating at an alarming rate. Large population-based representative surveys have been reported in Western countries to estimate the prevalence of the disease. However, there is paucity of data as far as developing nations are concerned. Asia is the world's largest continent accommodating maximum number of under-developed and developing countries with an unclear picture of prevalence of CKD. Current review attempts to give an insight to the prevalence of CKD in this region by combining population-based surveys. This review will assist in estimating the burden of CKD in Asia, so that appropriate control measures could be designed.

Upper reference limits for high-sensitivity cardiac troponin T and N-terminal fragment of the prohormone brain natriuretic peptide in patients with CKD

Authors

Nisha Bansal,Leila R Zelnick,Christie M Ballantyne,Paulo HM Chaves,Robert H Christenson,Josef Coresh,Christopher R deFilippi,James A de Lemos,Lori B Daniels,Alan S Go,Jiang He,S Susan Hedayati,Kunihiro Matsushita,Vijay Nambi,Michael G Shlipak,Jonathan J Taliercio,Stephen L Seliger,Lawrence J Appel,Harold I Feldman,James P Lash,Robert G Nelson,Panduranga S Rao,Mahboob Rahman,Vallabh O Shah,Raymond R Townsend,Mark L Unruh

Journal

American Journal of Kidney Diseases

Published Date

2022/3/1

Rationale & ObjectiveThe utility of conventional upper reference limits (URL) for N-terminal pro–brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hsTnT) in chronic kidney disease (CKD) remains debated. We analyzed the distribution of hsTnT and NT-proBNP in people with CKD in ambulatory settings to examine the diagnostic value of conventional URL in this population.Study DesignObservational study.Setting & ParticipantsWe studied participants of the Chronic Renal Insufficiency Cohort (CRIC) with CKD and no self-reported history of cardiovascular disease.ExposureEstimated glomerular filtration rate (eGFR).OutcomeNT-proBNP and hsTnT at baseline.Analytical ApproachWe described the proportion of participants above the conventional URL for NT-proBNP (125 pg/mL) and hsTnT (14 ng/L) overall and by eGFR. We then estimated 99th percentile URL for NT-proBNP and hsTnT …

Clinical applications measuring arterial stiffness: an expert consensus for the application of cardio-ankle vascular index

Authors

Matthew J Budoff,Bruce Alpert,Julio A Chirinos,Bo Fernhall,Naomi Hamburg,Kazuomi Kario,Iftikhar Kullo,Kunihiro Matsushita,Toru Miyoshi,Hirofumi Tanaka,Ray Townsend,Paul Valensi

Journal

American journal of hypertension

Published Date

2022/5/1

BACKGROUND The purpose of this document is to provide clinicians with guidance, using expert consensus, to help summarize evidence and offer practical recommendations. METHODS Expert Consensus Documents are intended to provide guidance for clinicians in areas in which there are no clinical practice guidelines, especially for new and evolving tests such as arterial stiffness measurements, until any formal guidelines are released. RESULTS This expert consensus document is intended as a source of information for decision-making and to guide clinician–patient discussions in various clinical scenarios. CONCLUSIONS The goal is to help clinicians and patients make a more informed decision together.

Periodontal disease measures and risk of incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study

Authors

Lubaina T Arsiwala,Yejin Mok,Chao Yang,Junichi Ishigami,Elizabeth Selvin,James D Beck,Matthew A Allison,Gerardo Heiss,Ryan T Demmer,Kunihiro Matsushita

Journal

Journal of periodontology

Published Date

2022/7

Background The association of periodontal disease with atherosclerotic cardiovascular diseases is well known, but not specifically with incident peripheral artery disease (PAD). Therefore, we studied the associations of periodontal disease with incident PAD in a population‐based setting. Methods Among 9,793 participants (aged 53–75 years) without prevalent PAD, self‐reported history of periodontal disease was ascertained. Of these, 5,872 participants underwent full‐mouth examinations from which periodontal status was defined using the US Centers for Disease Control and Prevention‐American Academy of Periodontology (CDC‐AAP) definition. We quantified the association of periodontal disease with incident PAD (defined by hospital admission diagnosis or procedures) using multivariable Cox regression models. Results During a median follow‐up of 20.1 years, 360 participants (3.6%) developed PAD …

Impact of socioeconomic status on mortality and readmission in patients with heart failure with reduced ejection fraction: the ARIC study

Authors

Lena Mathews,Ning Ding,Yejin Mok,Jung‐Im Shin,Deidra C Crews,Wayne D Rosamond,Anna‐Kucharska Newton,Patricia P Chang,Chiadi E Ndumele,Josef Coresh,Kunihiro Matsushita

Journal

Journal of the American Heart Association

Published Date

2022/9/20

Background Low socioeconomic status (SES) is associated with a higher risk of heart failure (HF). The contribution of individual and neighborhood SES to the prognosis and quality of care for HF with reduced ejection fraction is not clear yet has important implications. Methods and Results We examined 728 participants of the ARIC (Atherosclerosis Risk in Communities) study (mean age, 78.2 years; 34% Black participants; 46% women) hospitalized with HF with reduced ejection fraction (ejection fraction <50%) between 2005 and 2018. We assessed associations between education, income, and area deprivation index with mortality and HF readmission using multivariable Cox models. We also evaluated the use of guideline‐directed medical therapy (optimal: ≥3 of ß‐blockers, mineralocorticoid receptor antagonist, angiotensin‐converting enzyme inhibitors, or angiotensin receptor blockers; acceptable: at least 2 …

Time-updated changes in estimated GFR and proteinuria and major adverse cardiac events: findings from the chronic renal insufficiency cohort (CRIC) study

Authors

Jordana B Cohen,Wei Yang,Liang Li,Xiaoming Zhang,Zihe Zheng,Paula Orlandi,Nisha Bansal,Rajat Deo,James P Lash,Mahboob Rahman,Jiang He,Tariq Shafi,Jing Chen,Debbie L Cohen,Kunihiro Matsushita,Michael G Shlipak,Myles Wolf,Alan S Go,Harold I Feldman,Lawrence J Appel,Robert G Nelson,Panduranga S Rao,Vallabh O Shah,Raymond R Townsend,Mark L Unruh

Journal

American Journal of Kidney Diseases

Published Date

2022/1/1

Rationale & ObjectiveEvaluating repeated measures of estimated glomerular filtration rate (eGFR) and urinary protein-creatinine ratio (UPCR) over time may enhance our ability to understand the association between changes in kidney parameters and cardiovascular disease risk.Study DesignProspective cohort study.Setting & ParticipantsAnnual visit data from 2,438 participants in the Chronic Renal Insufficiency Cohort (CRIC).ExposuresAverage and slope of eGFR and UPCR in time-updated, 1-year exposure windows.OutcomesIncident heart failure, atherosclerotic cardiovascular disease events, death, and a composite of incident heart failure, atherosclerotic cardiovascular disease events, and death.Analytical ApproachA landmark analysis, a dynamic approach to survival modeling that leverages longitudinal, iterative profiles of laboratory and clinical information to assess the time-updated 3-year risk of adverse …

Race-and gender-based differences in cardiac structure and function and risk of heart failure

Authors

Alvin Chandra,Hicham Skali,Brian Claggett,Scott D Solomon,Joseph S Rossi,Stuart D Russell,Kunihiro Matsushita,Dalane W Kitzman,Suma H Konety,Thomas H Mosley,Patricia P Chang,Amil M Shah

Journal

Journal of the American College of Cardiology

Published Date

2022/2/1

Background Although heart failure (HF) risk and cardiac structure/function reportedly differ according to race and gender, limited data exist in late life when risk of HF is highest. Objectives The goal of this study was to evaluate race/gender–based differences in HF risk factors, cardiac structure/function, and incident HF in late life. Methods This analysis included 5,149 HF-free participants from ARIC (Atherosclerosis Risk In Communities), a prospective epidemiologic cohort study, who attended visit 5 (2011-2013) and underwent echocardiography. Participants were subsequently followed up for a median 5.5 years for incident HF/death. Results Patients’ mean age was 75 ± 5 years, 59% were women, and 20% were Black. Male gender and Black race were associated with lower mean left ventricular ejection fraction. Black race was also associated with greater left ventricular wall thickness and concentricity …

Association of left atrial structure and function with heart failure in older adults

Authors

Riccardo M Inciardi,Brian Claggett,Masatoshi Minamisawa,Sung-Hee Shin,Senthil Selvaraj,Alexandra Gonçalves,Wendy Wang,Dalane Kitzman,Kunihiro Matsushita,Narayana G Prasad,Jimmy Su,Hicham Skali,Amil M Shah,Lin Yee Chen,Scott D Solomon

Journal

Journal of the American College of Cardiology

Published Date

2022/4/26

Background Limited data exist to characterize novel measures of left atrial (LA) structure and function in older adults without prevalent heart failure (HF). Objectives The aim was to assess reference range of LA measures, their associations with N-terminal pro–B-type natriuretic-peptide (NT-proBNP) and the related risk for incident HF or death. Methods We analyzed LA structure (LA maximal [LAViMax] and minimal volume indexed by body surface area) and function (LA emptying fraction, LA reservoir, conduit, and contraction strain) in 4,901 participants from the ARIC (Atherosclerosis Risk In Communities) study (mean age 75 ± 5 years, 40% male, and 19% Black) without prevalent HF. We assessed sex-specific 10th and 90th percentile ARIC-based reference limits in 301 participants free of prevalent cardiovascular disease, and related LA measures to NT-proBNP and incident HF or death (median follow-up of 5 …

Association of estimated GFR calculated using race-free equations with kidney failure and mortality by black vs non-black race

Authors

Orlando M Gutiérrez,Yingying Sang,Morgan E Grams,Shoshana H Ballew,Aditya Surapaneni,Kunihiro Matsushita,Alan S Go,Michael G Shlipak,Lesley A Inker,Nwamaka D Eneanya,Deidra C Crews,Neil R Powe,Andrew S Levey,Josef Coresh,Morgan E Grams,Andrew S Levey,Lesley A Inker,Michael Shlipak,Orlando M Gutierrez,Paul Muntner,Suzanne Judd,Katharine Cheung,Nisha Bansal,Chi-yuan Hsu,James Sondheimer,Jonathan Taliercio,Milda Saunders,Elizabeth Selvin,Dan Wang,Shoshana H Ballew,Ron T Gansevoort,Tsuneo Konta,Kevan Polkinghorne,Elke Schaffner,Jingsha Chen,Mark Woodward,Chronic Kidney Disease Prognosis Consortium

Journal

Jama

Published Date

2022/6/21

ImportanceAt a given estimated glomerular filtration rate (eGFR), individuals who are Black have higher rates of mortality and kidney failure with replacement therapy (KFRT) compared with those who are non-Black. Whether the recently adopted eGFR equations without race preserve racial differences in risk of mortality and KFRT at a given eGFR is unknown.ObjectiveTo assess whether eGFR equations with and without race and cystatin C document racial differences in risk of KFRT and mortality in populations including Black and non-Black participants.Design, Setting, and ParticipantsRetrospective individual-level data analysis of 62 011 participants from 5 general population and 3 chronic kidney disease (CKD) US-based cohorts with serum creatinine, cystatin C, and follow-up for KFRT and mortality from 1988 to 2018.ExposuresChronic Kidney Disease Epidemiology Collaboration equation with serum …

Coronary artery disease and heart failure with preserved ejection fraction: the ARIC study

Authors

Jenine E John,Brian Claggett,Hicham Skali,Scott D Solomon,Jonathan W Cunningham,Kunihiro Matsushita,Suma H Konety,Dalane W Kitzman,Thomas H Mosley,Donald Clark III,Patricia P Chang,Amil M Shah

Journal

Journal of the American Heart Association

Published Date

2022/9/6

Background Whether coronary artery disease (CAD) is a significant risk factor for heart failure (HF) with preserved ejection fraction (HFpEF) is unclear. Methods and Results Among 9902 participants in the ARIC (Atherosclerosis Risk in Communities) study, we assessed the association of incident CAD with subsequent incident HFpEF (left ventricular ejection fraction [≥50%]) and HF with reduced ejection fraction (HFrEF; left ventricular ejection fraction <50%) using survival models with time‐updated variables. We also assessed the extent to which echocardiographic correlates of prevalent CAD account for the relationship between CAD and incident HFpEF. Over 13‐year follow‐up, incident CAD developed in 892 participants and 178 subsequently developed HF (86 HFrEF, 71 HFpEF). Incident HFrEF and HFpEF risk were both greatest early after the CAD event. At >1 year post‐CAD event, adjusted incidence of …

Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: The Atherosclerosis Risk in Communities (ARIC) study

Authors

Keeron Stone,Simon Fryer,James Faulkner,Michelle L Meyer,Kevin Heffernan,Anna Kucharska-Newton,Gabriel Zieff,Craig Paterson,Kunihiro Matsushita,Timothy M Hughes,Hirofumi Tanaka,Lee Stoner

Journal

Atherosclerosis

Published Date

2022/1/1

Background & aimsAtherosclerosis and arteriosclerosis contribute to vascular aging and cardiovascular disease (CVD) risk. Both processes can be assessed simply in the lower-limbs and reflect systemic pathology. However, only atherosclerosis is routinely assessed, typically via ankle-brachial index (ABI). Arteriosclerosis can be assessed using femoral-ankle pulse wave velocity (faPWV), but no studies have identified whether ABI and faPWV similarly associate with overt CVD and risk factors, nor whether faPWV confers additional information. The aims of this study were to (i) compare associations of ABI and faPWV with traditional CVD risk factors, including age, sex, systolic blood pressure (SBP), high-density lipoprotein (HDL), total cholesterol (TC), smoking, and diabetes; and (ii) determine the independent and additive associations of ABI and faPWV with a composite measure of prevalent CVD.MethodsWe …

A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

Authors

Stephen A Williams,Rachel Ostroff,Michael A Hinterberg,Josef Coresh,Christie M Ballantyne,Kunihiro Matsushita,Christian E Mueller,Joan Walter,Christian Jonasson,Rury R Holman,Svati H Shah,Naveed Sattar,Roy Taylor,Michael E Lean,Shintaro Kato,Hiroaki Shimokawa,Yasuhiko Sakata,Kotaro Nochioka,Chirag R Parikh,Steven G Coca,Torbjørn Omland,Jessica Chadwick,David Astling,Yolanda Hagar,Natasha Kureshi,Kelsey Loupy,Clare Paterson,Jeremy Primus,Missy Simpson,Nelson P Trujillo,Peter Ganz

Journal

Science translational medicine

Published Date

2022/4/6

A reliable, individualized, and dynamic surrogate of cardiovascular risk, synoptic for key biologic mechanisms, could shorten the path for drug development, enhance drug cost-effectiveness and improve patient outcomes. We used highly multiplexed proteomics to address these objectives, measuring about 5000 proteins in each of 32,130 archived plasma samples from 22,849 participants in nine clinical studies. We used machine learning to derive a 27-protein model predicting 4-year likelihood of myocardial infarction, stroke, heart failure, or death. The 27 proteins encompassed 10 biologic systems, and 12 were associated with relevant causal genetic traits. We independently validated results in 11,609 participants. Compared to a clinical model, the ratio of observed events in quintile 5 to quintile 1 was 6.7 for proteins versus 2.9 for the clinical model, AUCs (95% CI) were 0.73 (0.72 to 0.74) versus 0.64 (0.62 to 0 …

See List of Professors in Kunihiro Matsushita University(Johns Hopkins University)

Kunihiro Matsushita FAQs

What is Kunihiro Matsushita's h-index at Johns Hopkins University?

The h-index of Kunihiro Matsushita has been 72 since 2020 and 89 in total.

What are Kunihiro Matsushita's top articles?

The articles with the titles of

Metabolomic Association and Risk Prediction With Heart Failure in Older Adults

Discrepancies between cystatin C–based and creatinine-based eGFR

Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study

Racial differences in trends and prognosis of guideline-directed medical therapy for heart failure with reduced ejection fraction: the Atherosclerosis Risk in Communities (ARIC …

Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis

Incidence of dementia following hospitalization with infection among adults in the atherosclerosis risk in communities (ARIC) study cohort

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Effects of cuff size on the accuracy of blood pressure readings: the Cuff (SZ) randomized crossover trial

...

are the top articles of Kunihiro Matsushita at Johns Hopkins University.

What are Kunihiro Matsushita's research interests?

The research interests of Kunihiro Matsushita are: Cardiovascular Disease, Chronic Kidney Disease, Risk Prediction

What is Kunihiro Matsushita's total number of citations?

Kunihiro Matsushita has 93,725 citations in total.

What are the co-authors of Kunihiro Matsushita?

The co-authors of Kunihiro Matsushita are Josef Coresh, MD, PhD, Scott Solomon, Andrew S. Levey, Christie Ballantyne, Marcello Tonelli, Lawrence Appel.

    Co-Authors

    H-index: 194
    Josef Coresh, MD, PhD

    Josef Coresh, MD, PhD

    Johns Hopkins University

    H-index: 190
    Scott Solomon

    Scott Solomon

    Harvard University

    H-index: 182
    Andrew S. Levey

    Andrew S. Levey

    Tufts University

    H-index: 169
    Christie Ballantyne

    Christie Ballantyne

    Baylor College of Medicine

    H-index: 164
    Marcello Tonelli

    Marcello Tonelli

    University of Calgary

    H-index: 153
    Lawrence Appel

    Lawrence Appel

    Johns Hopkins University

    academic-engine

    Useful Links